Sign In
Buy KYTX
Kyverna Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 88.82. In total, the insiders bought 19.89M and sold 29.3M KYTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
88.82 |
| ● Buy | 19.89M shares |
| ● Sell | 29.3M shares |
|
94% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Oct 21, 2024 Buy |
Aktar Mert Director |
87 741 Value: $456.3K |
||
|
Oct 21, 2024 Buy |
Aktar Mert Insider |
0 Value: $0 |
||
|
Sep 16, 2024 Buy |
Biddle Warner Weston Chief Executive Officer |
2 579 259 Value: $17.8M |
||
|
Sep 16, 2024 Buy |
Shaw Christi Director |
66 592 Value: $458.8K |
||
|
Sep 16, 2024 Buy |
Biddle Warner Weston Insider |
0 Value: $0 |
||
|
Sep 16, 2024 Buy |
Shaw Christi Insider |
0 Value: $0 |
||
|
Sep 16, 2024 Buy |
Biddle Warner Weston Chief Executive Officer |
2 579 259 Value: $17.8M |
||
|
Sep 16, 2024 Buy |
Shaw Christi Director |
66 592 Value: $458.8K |
||
|
Sep 16, 2024 Buy |
Biddle Warner Weston Insider |
0 Value: $0 |
||
|
Sep 16, 2024 Buy |
Shaw Christi Insider |
0 Value: $0 |
||
|
Apr 11, 2024 Buy |
Biddle Warner Weston Chief Executive Officer |
332 500 Value: $685.0K |
||
|
Apr 11, 2024 Buy |
Jones Ryan Alexander Chief Financial Officer |
74 000 Value: $152.4K |
||
|
Apr 11, 2024 Buy |
Walker Karen Marie Chief Technology Officer |
80 000 Value: $164.8K |
||
|
Apr 11, 2024 Buy |
Biddle Warner Weston Chief Executive Officer |
332 500 Value: $685.0K |
||
|
Apr 11, 2024 Buy |
Jones Ryan Alexander Chief Financial Officer |
74 000 Value: $152.4K |
||
|
Apr 11, 2024 Buy |
Walker Karen Marie Chief Technology Officer |
80 000 Value: $164.8K |
||
|
Feb 12, 2024 Buy |
Gilead Sciences, Inc. 10 Percent Owner |
910 000 Value: $20.0M |
||
|
Feb 12, 2024 Buy |
Gilead Sciences, Inc. 10 Percent Owner |
3 216 119 Value: $0 |
||
|
Feb 12, 2024 Sell |
Gilead Sciences, Inc. 10 Percent Owner |
6 890 744 Value: $0 |
||
|
Feb 12, 2024 Sell |
Gilead Sciences, Inc. 10 Percent Owner |
7 746 139 Value: $0 |
||
|
Feb 12, 2024 Buy |
Gilead Sciences, Inc. 10 Percent Owner |
910 000 Value: $20.0M |
||
|
Feb 12, 2024 Buy |
Gilead Sciences, Inc. 10 Percent Owner |
3 216 119 Value: $0 |
||
|
Feb 12, 2024 Sell |
Gilead Sciences, Inc. 10 Percent Owner |
6 890 744 Value: $0 |
||
|
Feb 12, 2024 Sell |
Gilead Sciences, Inc. 10 Percent Owner |
7 746 139 Value: $0 |
||
|
Feb 07, 2024 Buy |
Clark Ian T Director |
38 736 Value: $171.2K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
